Ueda Hiroki, Ban Daisuke, Kudo Atsushi, Ochiai Takanori, Tanaka Shinji, Tanabe Minoru
Department of Hepatobiliary and Pancreatic Surgery, Graduate School of Medicine, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan.
Department of Molecular Oncology, Graduate School of Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
World J Surg. 2017 Jul;41(7):1882-1889. doi: 10.1007/s00268-017-3912-z.
Postoperative cholangitis is one of the major late complications after pancreaticoduodenectomy (PD), and recurrent cholangitis has a negative impact on patients' quality of life. However, detailed reports are scarce. The aim of this study was to investigate the clinical features of postoperative cholangitis after PD.
Between January 2007 and December 2013, 155 consecutive patients underwent PD. Of these, 113 patients were included in this study. Cholangitis was diagnosed according to the criteria in the revised Tokyo Guidelines 2013, and repeated cholangitis with three or more episodes was defined as 'refractory cholangitis'. Data from patients with refractory cholangitis were retrospectively analyzed.
Refractory cholangitis was observed in 21 patients (18.6%). Of these, 17 patients experienced cholangitis within 1 year after PD, and 10 patients had biliary strictures. These patients required an average of two interventional or endoscopic treatments for stricture dilatation, which led to remission. The 2-year cumulative incidence rate for refractory cholangitis was 18.9% (95% CI 11.65-26.15). Multivariate analysis revealed five risk factors for developing refractory cholangitis: benign disease (odds ratio [OR] 18.52; P = 0.001), long operation time (OR 18.73; P = 0.002), elevated C-reactive protein (OR 6.55; P = 0.014), elevated alkaline phosphatase (OR 6.03; P = 0.018), and the presence of pneumobilia (OR 28.81; P = 0.009).
Postoperative refractory cholangitis after PD usually developed within a year. Almost half of the patients had biliary strictures, and aggressive dilatation might be effective to achieve remission in these patients.
术后胆管炎是胰十二指肠切除术(PD)后主要的晚期并发症之一,复发性胆管炎对患者生活质量有负面影响。然而,详细报道较少。本研究旨在探讨PD术后胆管炎的临床特征。
2007年1月至2013年12月,155例患者连续接受了PD手术。其中,113例患者纳入本研究。根据2013年修订的东京指南标准诊断胆管炎,将发作三次或更多次的复发性胆管炎定义为“难治性胆管炎”。对难治性胆管炎患者的数据进行回顾性分析。
21例患者(18.6%)出现难治性胆管炎。其中,17例患者在PD术后1年内发生胆管炎,10例患者有胆管狭窄。这些患者平均需要两次介入或内镜治疗以扩张狭窄,从而实现缓解。难治性胆管炎的2年累积发病率为18.9%(95%CI 11.65-26.15)。多因素分析显示了发生难治性胆管炎的五个危险因素:良性疾病(比值比[OR]18.52;P=0.001)、手术时间长(OR 18.73;P=0.002)、C反应蛋白升高(OR 6.55;P=0.014)、碱性磷酸酶升高(OR 6.03;P=0.018)和气胆的存在(OR 28.81;P=0.009)。
PD术后难治性胆管炎通常在1年内发生。几乎一半的患者有胆管狭窄,积极扩张可能对这些患者实现缓解有效。